Last reviewed · How we verify
Lumacaftor, Ivacaftor Drug Combination — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Lumacaftor, Ivacaftor Drug Combination (Lumacaftor, Ivacaftor Drug Combination) — Carmel Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Lumacaftor, Ivacaftor Drug Combination TARGET | Lumacaftor, Ivacaftor Drug Combination | Carmel Medical Center | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Lumacaftor, Ivacaftor Drug Combination CI watch — RSS
- Lumacaftor, Ivacaftor Drug Combination CI watch — Atom
- Lumacaftor, Ivacaftor Drug Combination CI watch — JSON
- Lumacaftor, Ivacaftor Drug Combination alone — RSS
Cite this brief
Drug Landscape (2026). Lumacaftor, Ivacaftor Drug Combination — Competitive Intelligence Brief. https://druglandscape.com/ci/lumacaftor-ivacaftor-drug-combination. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab